Cannvas MedTech (CSE:MTEC) (“Cannvas” or the “Company”), a leading business technology company in the cannabis space, is pleased to announce its intent, operating under its newly-formed Cannvas Cannabis Acquisitions brand, to create a network of high-tech learning and fulfillment centres across Canada, improving accessibility to free and unbiased education about the potential benefits of medical and adult-use cannabis while providing curious consumers with on-site retail options from leading cannabis brands. Operating under the brand Cannvas Marché, each location will feature on-site medical and educational staff, digital learning resources and a fulfillment program, with the first centre expected to open in Toronto in early 2019.

“This is an exciting venture unlike anything being done in today’s market, benefitting active and potential medical and adult-use cannabis users by improving accessibility to free cannabis education while providing visitors to the centre with the opportunity for immediate fulfillment on-site,” said Steve Loutskou, Chief Operating Officer of Cannvas MedTech Inc and Chief Executive Officer of Cannvas Cannabis Acquisitions. “Our hope is that anyone of legal age will be able to visit their local Cannvas Marché, sit in on seminars pertaining to their lifestyle, speak with a health practitioner and, if they choose, interact with one of our retail partners to purchase cannabis products suited to their needs.”


Initial renderings for the Cannvas Marché concept are available at CannvasMarche.com and the Company has entered into a Memorandum of Understanding (MOU) with a leading finance incubator of licensed cannabis ventures as its strategic realtor to advise on viability of certain locations in the city’s downtown core for the first cannabis education and fulfillment centre. Each centre will feature hands-on education sessions on a variety of cannabis-related topics with no pressure to purchase or consume. Sessions will be led by a registered health practitioner or certified educator and showcase original physician-backed content created for the Cannvas.Me platform. Visitors can register for free seminars each week or drop in anytime to access the content on their own through tablets and touch-screens.

“It’s never easy being the first to do anything and we believe strongly in the mission of our Cannvas Marché concept to provide accessible and unbiased cannabis education to consumers at all stages of cannabis curiosity while ensuring the overall long-term viability of this learning and retail hub,” said Shawn Moniz, Chief Executive Officer of Cannvas MedTech. “We have worked diligently to evaluate all potential revenue streams and are pleased with our projections both in the short- and long-term, and look forward to bringing our network of strategic partners into this project should there be a fit.”

The unique aspect of the Cannvas Marché is its fulfillment aspect. Each centre will include a retail marketplace component featuring leading cannabis brands ready to fulfill the needs of consumers wishing to purchase cannabis products. The proprietary retail business model Cannvas has developed ensures the Company remains true to its mission of remaining unbiased and offering content with no hidden agenda. Cannvas has already engaged several brands and are in discussions to issue Letters of Intent (LOIs) in the near future.

“We’re taking what Apple does with its Genius Bar and learning seminars and applying it to the cannabis retail experience to offer Canadians a value-added educational experience as they explore the world of legalized cannabis,” said Daniel Davidzon, Marketing Manager for Cannvas MedTech Inc. “In taking the same approach to a bricks-and-mortar location as we do online, we’re able to offer visitors to our Cannvas Marché centres unparalleled access to reliable and relevant information, arming them with the knowledge they need to be confident in taking the next steps in their cannabis journey while adding value with an immediate option for fulfillment.”

Cannvas is currently engaging with top regulators and compliance bodies as it works aggressively to begin the first phase of creating this first-of-its-kind public cannabis education and fulfillment centre. Through a creative licensing model, the Company intends to expand the reach of its Cannvas Marché centres to communities across Canada and use its strategic partnerships to further integrate the Cannvas.Me platform into existing retail experiences.

The project speaks to the strengths of the Cannvas executive team and its wealth of experience across a range of sectors. Steve Loutskou, COO of Cannvas MedTech Inc and CEO of Cannvas Cannabis Acquisitions, brings a successful track record in real estate and technology while Shawn Moniz, CEO at Cannvas MedTech has an extensive background in pharmacy and experiential patient education. Cannvas has also retained Nick Pavlov as its real estate advisor to vet properties in downtown Toronto. A past member of the Diversity Task Force and panel member (professional standards) for the Toronto Real Estate Board, Nick supplies real estate and market guidance within the retail and commercial sphere for cannabis-based activities, has represented three of Canada’s chartered banks as their selling specialist and has appeared in media on HGTV, Global TV, CBC and various print outlets.

About Cannvas Cannabis Acquisitions

Cannvas Cannabis Acquisitions is a wholly-owned subsidiary of Cannvas MedTech Inc., with a focus on investment and acquisition in the expanding global cannabis sector. Cannvas Cannabis seeks to complement Cannvas’ current product offering through continuous development, strategic investments and acquisitions in the cannabis sector. Related companies may include, but are not limited to technology, marketing and design, food and nutraceuticals, regulation and enforcement, new product development, gear and paraphernalia, retail stores and dispensaries, and testing labs.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation.

Source: www.newswire.ca

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less